Prussian Blue Insoluble
Prussian blue (insoluble ferric hexacyanoferrate) is an ion-exchange compound that binds radioactive cesium-137 and thallium ions with high affinity within the gastrointestinal tract, preventing their absorption and reabsorption, thereby accelerating their elimination via fecal excretion. It is approved as an antidote for internal contamination with radioactive cesium-137 and non-radioactive thallium, significantly reducing their biological half-lives.
Berat Molekul
859,2000 g/mol
TPSA
428,00 Ų
Area Terapeutik
Mekanisme Kerja
Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.
SMILES
[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3]
InChI
InChI=1S/18CN.7Fe/c18*1-2;;;;;;;/q18*-1;3*+2;4*+3
Molecular Formula
C18Fe7N18
HBD / HBA
- / 36
Ikatan yang Dapat Dirotasi
0
Atom Berat
43
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Pertanyaan yang Sering Diajukan
Prussian blue (insoluble ferric hexacyanoferrate) is an ion-exchange compound that binds radioactive cesium-137 and thallium ions with high affinity within the gastrointestinal tract, preventing their absorption and reabsorption, thereby accelerating their elimination via fecal excretion. It is approved as an antidote for internal contamination with radioactive cesium-137 and non-radioactive thallium, significantly reducing their biological half-lives.
Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.
Yes, Prussian Blue Insoluble is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2096629. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 2724251. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="prussian-blue-insoluble"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/prussian-blue-insoluble/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/prussian-blue-insoluble/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/prussian-blue-insoluble/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="prussian-blue-insoluble"></drugfyi-drug>